These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33493729)

  • 1. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients.
    Singh CV; Jain S; Parveen S
    Am J Otolaryngol; 2021; 42(3):102892. PubMed ID: 33493729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients.
    Singh CV; Jain S; Parveen S; Deshmukh P
    Am J Otolaryngol; 2021; 42(4):103009. PubMed ID: 33846030
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the editor regarding "The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients".
    Verma RR; Gupta N; Singh M
    Am J Otolaryngol; 2021; 42(5):103103. PubMed ID: 34116850
    [No Abstract]   [Full Text] [Related]  

  • 4. The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated.
    Lechien JR; Hoch CC; Vaira LA; Saussez S
    Am J Otolaryngol; 2021; 42(4):103008. PubMed ID: 33810883
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial.
    Abdelalim AA; Mohamady AA; Elsayed RA; Elawady MA; Ghallab AF
    Am J Otolaryngol; 2021; 42(2):102884. PubMed ID: 33429174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies.
    Winn PZ; Hlaing T; Tun KM; Lei SL
    PLoS One; 2023; 18(8):e0288285. PubMed ID: 37531338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 with and without anosmia or dysgeusia: A case-control study.
    Dev N; Sankar J; Gupta N; Meena RC; Singh C; Gupta DK; Sen MK
    J Med Virol; 2021 Apr; 93(4):2499-2504. PubMed ID: 33417259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of smell and taste in COVID-19 infection in adolescents.
    Kumar L; Kahlon N; Jain A; Kaur J; Singh M; Pandey AK
    Int J Pediatr Otorhinolaryngol; 2021 Mar; 142():110626. PubMed ID: 33477014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial.
    Kasiri H; Rouhani N; Salehifar E; Ghazaeian M; Fallah S
    Int Immunopharmacol; 2021 Sep; 98():107871. PubMed ID: 34147912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should anosmia and dysgeusia be a concern for oral and maxillofacial surgeons during the COVID-19 pandemic?
    Alharbi H; You S; Katz J
    Oral Maxillofac Surg; 2022 Mar; 26(1):105-111. PubMed ID: 33954852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does COVID-19 cause permanent damage to olfactory and gustatory function?
    Paolo G
    Med Hypotheses; 2020 Oct; 143():110086. PubMed ID: 32721795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anosmia (smell failure) and dysgeusia (taste distortion) in COVID-19: it is genetic.
    Hendaus MA
    J Biomol Struct Dyn; 2023 Apr; 41(7):3162-3165. PubMed ID: 35147485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic.
    Krishnakumar HN; Momtaz DA; Sherwani A; Mhapankar A; Gonuguntla RK; Maleki A; Abbas A; Ghali AN; Al Afif A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):505-509. PubMed ID: 36209486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of triamcinolone acetonide nasal aerosol spray and fluticasone propionate aqueous solution spray in the treatment of spring allergic rhinitis.
    Small P; Houle PA; Day JH; Briscoe M; Gold M; Brodarec I; Ham Pong A; Mandl M; Spénard J; Phillips R; Furlan M
    J Allergy Clin Immunol; 1997 Nov; 100(5):592-5. PubMed ID: 9389286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Smell and Taste in Patients With Suspected COVID-19: Analyses of Patients' Reports on Social Media.
    Koyama S; Ueha R; Kondo K
    J Med Internet Res; 2021 Apr; 23(4):e26459. PubMed ID: 33788699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an absorbable gelatin dressing impregnated with triamcinolone within the olfactory cleft on polypoid rhinosinusitis smell disorders.
    Bardaranfar MH; Ranjbar Z; Dadgarnia MH; Atighechi S; Mirvakili A; Behniafard N; Sadeghi M; Abbaslu F; Baradaranfar A
    Am J Rhinol Allergy; 2014; 28(2):172-5. PubMed ID: 24717956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
    Hosseinpoor M; Kabiri M; Rajati Haghi M; Ghadam Soltani T; Rezaei A; Faghfouri A; Poustchian Gholkhatmi Z; Bakhshaee M
    Laryngoscope; 2022 Nov; 132(11):2209-2216. PubMed ID: 36054369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anosmia and dysgeusia in COVID-19: A systematic review.
    Carrillo-Larco RM; Altez-Fernandez C
    Wellcome Open Res; 2020; 5():94. PubMed ID: 32587902
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of smell and taste dysfunction in COVID-19 patients.
    Wong DKC; Gendeh HS; Thong HK; Lum SG; Gendeh BS; Saim A; Salina H
    Med J Malaysia; 2020 Sep; 75(5):574-581. PubMed ID: 32918429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of pentasodium diethylenetriamine pentaacetate in ameliorating anosmia post COVID-19.
    Imam MS; Abdelazim MH; Abdelazim AH; Ismaiel WF; Gamal M; Abourehab MAS; Alghamdi S; Alghamdi MA; Ghoneim MM; Elwany S
    Am J Otolaryngol; 2023; 44(4):103871. PubMed ID: 37018923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.